ALB, albumin, 213

N. diseases: 1198; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE In conclusion, albumin is an integrated marker of various adverse processes in HFpEF, including inflammation, subclinical liver disease, arterial stiffness, and renal disease. 31843232 2020
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE In elderly patients with diabetes, multiple regression analysis showed that serum bilirubin levels and albumin levels, both of which are major endogenous anti-oxidants, and chronic renal failure (or proliferative nephropathy) were significantly associated with HNA%, suggesting that HNA% may be a good biomarker for oxidative stress in those patients. 31672444 2020
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE To identify correlations of bone mineral density (BMD) and bone metabolism indices with the urine albumin to creatinine ratio (ACR) as an indicator of nephropathy in Chinese patients with type 2 diabetes (T2D). 30396213 2019
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Both analyses adjusted for demographics, eGFR, urinary albumin-creatinine ratio, and other kidney disease progression risk factors. 31128770 2019
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Proteinuria is strongly associated with kidney disease progression but the mechanisms underlying podocyte handling of serum proteins such as albumin and IgG remain to be elucidated. 30811433 2019
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Proximal tubule (PT) albumin overload is a critical process in the development of tubule-interstitial injury (TII), and consequently in progression of renal disease. 31560867 2019
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 AlteredExpression group BEFREE TP and ALB levels in nephropathy group were decreased compared with control group (p<0.01) and increased compared with treatment groups (p<0.05), while TG and Chol levels in nephropathy group were increased compared with control group (p<0.01) and decreased compared with treatment group (p<0.05). 31773705 2019
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Three clinical characteristics-age, urine dipstick for protein, and serum albumin-could predict likelihood of tubulointerstitial kidney disease on biopsy (model sensitivity of 79% and specificity of 84%). 30659059 2019
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Association between Sodium Intake and Urinary Fractional Albumin and Immunoglobulin G Excretion in Chronic Nondialytic Renal Disease: A Prospective Longitudinal Study. 31216544 2019
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 GeneticVariation group BEFREE Losartan therapy for ≥1year in sickle nephropathy results in lower albumin excretion with stable GFR. 28951038 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Currently, the investigation of kidney diseases is usually performed through the assessment of serum creatinine and urinary albumin. 30201372 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE The present study examined the role of (pro)renin receptor (PRR) in pathogenesis of albumin overload (AO)-induced nephropathy and activation of the intrarenal renin-angiotensin system (RAS) in rats. 29846109 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE We aimed to identify urinary biomarkers to early diagnosis nephropathy before identifiable alternations in kidney function or urine albumin excretion occurs. 30486327 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial. 29214305 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE In populations with or without renal impairment, SGLT2 inhibitors (particularly canagliflozin and empagliflozin) compared with placebo were associated with decreased urine albumin, improved albuminiuria, slowed progression to macroalbuminuria, and reduced the risk of worsening renal impairment, the initiation of kidney transplant, and death from renal disease. 29482993 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Early nephropathy was defined as an estimated glomerular filtration rate (≥60 ml/min) and urinary albumin excretion (≥30 mg/g). 30718148 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 AlteredExpression group BEFREE The results showed that both EPS1 and EPS2 exhibited potential anti-DN effects, including significantly decreasing GLU levels; suppressing ALB, BUN, CRE and UA levels; reducing serum lipid (TC, TG, VLDL-C and LDL-C) levels; improving renal antioxidant status (GSH-Px, SOD, CAT and MDA); and attenuating pathological nephropathy damage. 29309869 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Albumin-corrected calcium (cCa) is recommended over ionized calcium (iCa) in hemodialysis (HD) patients per the Kidney Disease: Improving Global Outcomes position statements due to cost and feasibility. 28853704 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE The study consisted of two parts: (1) a multicentre retrospective clinical study to assess the predictors of AKI during colistin therapy, defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria; and (2) bioinformatic and biochemical characterization of the possible interaction between human serum albumin and colistin. 30097635 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Glycated albumin and specific inflammatory mediators have been reported to play various roles in the pathogenesis of insulin resistance, atherosclerosis, coronary artery disease, retinopathy, and nephropathy. 29022053 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Tubular damage resulting in reduced albumin uptake or degradation has been suggested as one mechanism contributing to albuminuria in kidney disease. 29124787 2018
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Diabetic animals had clear nephropathy indicated by proteinuria and increased albumin excretion rate (AER) which were significantly decreased by PARP inhibition. 28224182 2017
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE The current categorization of chronic kidney disease (CKD) is based on biomarkers of the glomerular function (estimated glomerular filtration rate, eGFR) and injury (urinary albumin creatinine ratio, UACR) and provides information on the risk of death and of progression of kidney disease. 27771693 2017
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Objectives The aims of this study were to validate a semi-automated high-resolution electrophoretic technique to quantify urinary albumin in healthy and diseased cats, and to evaluate its diagnostic performance in cases of proteinuria and renal diseases. 27555488 2017
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.400 Biomarker group BEFREE Celastrol-albumin nanoparticles thus represents a promising treatment option for mesangioproliferative glomerulonephritis and similar glomerular diseases.Mesangial cell-mediated glomerulonephritis is a frequent cause of kidney disease. 29026082 2017